{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-261008","form_type":"8-K","ticker":"ACH","cik":"0000075252","company_name":"ACCENDRA HEALTH INC/VA/","filed_at":"2022-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:53.501335+00:00","generated_at":"2026-06-23T04:11:14.164504+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Owens & Minor cuts FY2022 guidance, announces executive reshuffle amid macro headwinds","bullets":["Preliminary Q3 GAAP EPS $0.15-$0.17; adjusted EPS $0.39-$0.41.","FY2022 adjusted EPS guidance cut to $2.50-$2.60 (prev. $2.85-$3.15); adjusted EBITDA $527-$537M (prev. $570-$610M).","CFO Andy Long becomes EVP/CEO of Products & Healthcare Services segment; Alex Bruni promoted to EVP/CFO.","COO Jeff Jochims resigns; separation agreement provides 1.5x salary and bonus severance.","Weakness attributed to unfavorable macro, lower hospital volumes, and elevated customer stocking."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-261008","json":"https://secwatch.observer/filing/0001193125-22-261008.json","markdown":"https://secwatch.observer/filing/0001193125-22-261008.md","text":"https://secwatch.observer/filing/0001193125-22-261008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/0001193125-22-261008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/d390830d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:11:14.164504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22d8131a2d","claim":"Alexander J. Bruni was appointed as Executive Vice President & Chief Financial Officer at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"Alexander J. Bruni, age 46, has been appointed Executive Vice President & Chief Financial Officer of the Company replacing Mr. Long effective October 12, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/0001193125-22-261008-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President & Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"942a8329bf","claim":"Andrew G. Long was appointed as Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment at ACCENDRA HEALTH INC/VA/.","evidence_excerpt":"Andrew G. Long, the Company’s Executive Vice President & Chief Financial Officer has been appointed as Executive Vice President, Chief Executive Officer of the Company’s Products & Healthcare Services segment, effective October 12, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/75252/000119312522261008/0001193125-22-261008-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Chief Executive Officer of Products & Healthcare Services Segment"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}